Dermatology Online Journal
Cutaneous umbilical endometriosis
- Author(s): Lee, Arnold
- Tran, Hien T
- Walters, Ruth F
- Yee, Herman
- Rosenman, Karla
- Sanchez, Miguel R
- et al.
Cutaneous umbilical endometriosisDepartment of Dermatology, New York University
Arnold Lee MD PhD, Hien T Tran MD PhD, Ruth F Walters MD, Herman Yee MD PhD, Karla Rosenman MD, Miguel R Sanchez MD
Dermatology Online Journal 14 (10): 23
A 35 year-old woman presented with a four-month history of a tender umbilical nodule that bleeds during her menstrual period. Physical examination showed a hyperpigmented umbilical nodule. A biopsy specimen showed fibrotic dermis with increased numbers of blood vessels and scattered glandular structures with areas of hemosiderin deposition consistent with a diagnosis of endometriosis. Cutaneous umbilical endometriosis is rare, with an estimated incidence of 0.5 to 1.0 percent. Although anti-gonadotropin medications, such as danazol, have been used for symptomatic control, but surgical excision is the treatment of choice owing to the possibility of malignant degeneration of cutaneous endometriosis.
|Figure 1||Figure 2|
A 35-year-old woman presented to the Dermatology Clinic at Bellevue Hospital Center with a four-month history of a tender umbilical mass that bleeds during her menstrual period. A punch biopsy was performed. Her past medical history includes perianal warts and vulvar lichen simplex chronicus for which she applies hydrocortisone 2.5 percent cream and econazole cream twice daily to her vulva.
A hyperpigmented umbilical nodule was present.
Within the reticular dermis, there are glands lined by bland cuboidal cells that are surrounded by a stroma of spindle cells in which there are focal hemosiderin deposits.
Endometriosis is the presence of functional endometrial tissue outside the uterine cavity. It typically occurs in women during their reproductive years. Extrapelvic endometriosis in women with endometriosis has been estimated to occur in up 12 percent . Although ectopic endometrial tissue has been documented in almost every organ of the body, the intestine, skin, inguinal region, and lungs are the most frequently observed sites [2, 3]. In particular, cutaneous endometriosis occurs most commonly in surgical scars after abdominal or pelvic operations . These operations include hysterectomy, tubal ligation, Caesarean section, episiotomy, and laparoscopy. In contrast, umbilical endometriosis is uncommon, with an estimated incidence of 0.5 to 1 percent [1, 4].
The classic presentation for cutaneous endometriosis is a parous woman, who complains of a tender nodule with associated swelling and slight bleeding during the menses . The use of non-invasive imaging modalities, such as sonography and computed tomography scans, to help distinguish cutaneous endometriosis from a suture granuloma, lipoma, abscess, cyst, or incisional hernia has met with limited success . Immunohistochemical staining with CD10 can be used to confirm the presence of endometrial stroma, with an estimated sensitivity of 88 percent . A single case report using dermoscopy has described the presence of red atolls that were homogenously distributed in the cutaneous endometrial lesions. Correlations between dermatoscopic and histopathologic features have shown that these red atolls are related to the presence of multiple irregular glands that contain red blood cells, which are embedded in a cellular stroma. The homogeneous red hue is associated with the presence of myxoid, vascular stroma, which contains extravasated erythrocytes .
Multiple theories have been proposed to explain the development of endometriosis. Endometrioma in scars are likely due to direct inoculation and implantation of endometrial cells . This theory is consistent with experiments that demonstrate that transplantation of normal menstrual effluent to the abdominal wall results in subcutaneous endometriosis . For cases of spontaneous cutaneous endometriosis, the endometrial cells may reach the sites via lymphatic or vascular dissemination [1, 3]. It has been hypothesized that these ectopically implanted endometrial cells do not proliferate to form endometrioma. Instead, they lodge in certain tissues with a high degree of pleuripotentiality and induce cell replication .
Surgical excision of cutaneous endometriosis is the treatment of choice. Malignant degeneration of extragonadal endometriosis occurs in 21.3 percent. However, malignant conditions, such as endometrial carcinoma that arise from cutaneous endometriosis in surgical scars, are rare at 0.3 to 1 percent [5, 8]. Anti-gonadotropin medications, such as danazol, have been used to provide relief of symptoms such as pain [1, 2]. However, this type of medication has undesirable androgenic side-effects, such as amenorrhea, hirsutism, weigh gain, and acne, which may influence compliance [2, 9].
References1. Friedman PM, Rico MJ. Cutaneous endometriosis. Dermatol Online J 2000; 6: 8 PubMed
2. Nirula R, Greaney GC. Incisional endometriosis: an underappreciated diagnosis in general surgery. J Am Coll Surg 2000; 190: 404 PubMed
3. Choi SW, et al. A case of cutaneous endometriosis developed in postmenopausal woman receiving hormonal replacement. J Am Acad Dermatol 1999; 41: 327 PubMed
4. De Giorgi V, et al. Cutaneous endometriosis: non-invasive analysis by epiluminescence microscopy. Clin Exp Dermatol 2003; 28: 315 PubMed
5. Chene G, et al. Malignant degeneration of perineal endometriosis in episiotomy scar, case report and review of the literature. Int J Gynecol Cancer 2007; 17: 709 PubMed
6. Amato M, Levitt R. Abdominal wall endometriosis: CT findings. J Comput Assist Tomogr 1984; 8: 1213 PubMed
7. Ridley JH, Edwards K. Experimental endometriosis in the human. Am J Obstet Gynecol 1958; 76: 783 PubMed
8. Heaps JM, et al. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75: 1023 PubMed
9. Purvis RS, Tyring SK. Cutaneous and subcutaneous endometriosis: surgical and hormonal therapy. J Dermatol Surg Oncol 1994; 20: 693 PubMed
© 2008 Dermatology Online Journal